HIGHLIGHTS
- who: Maoxuan Lin from the Published in partnership with The Hormel Institute, University of Minnesota have published the paper: Single-cell transcriptomic profiling for inferring tumor origin and mechanisms of therapeutic resistance, in the Journal: (JOURNAL)
- what: In this n-of-1 study, the authors demonstrate the potential clinical utility of scRNA-Seq for inferring tumor origin and mechanisms of therapeutic resistance.
- how: The study was conducted in accordance with the U.S. Common Rule.
- future: As this study lacks in_vitro and in_vivo studies to confirm the computational findings from scRNA . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.